The announcement came the day after the World Health Organization declared mpox a global public health emergency.

Sweden said Thursday that it had confirmed a case of the more contagious version of mpox currently circulating in central and eastern Africa.

It is the first known infection of the strain outside of Africa.

On Wednesday, the World Health Organization declared mpox — formerly known as monkeypox — a global public health emergency for the second time in two years, following an outbreak in the Democratic Republic of Congo that has spread to 12 other countries in the region.

    • werefreeatlast@lemmy.world
      link
      fedilink
      English
      arrow-up
      3
      arrow-down
      14
      ·
      3 months ago

      It’s not even airborne and only affects…the gay… 1 month later, oh it’s mildly airborne so wear a mask…1 year later, oh don’t walk where there are dead people and take a shower when you’re home…2 years, ok stay home, this will be over if we stay home for 20 consecutive days. 3 years into it…the US has released a prototype version of the vaccine, they’ll try it in …treat people in Africa since that’s where it started…oh the now modified and effective drug is available, get it if you’re gay or if you work, you know, for your safety.

  • Media Bias Fact Checker@lemmy.worldB
    link
    fedilink
    English
    arrow-up
    5
    arrow-down
    9
    ·
    3 months ago
    NBC News - News Source Context (Click to view Full Report)

    Information for NBC News:

    MBFC: Left-Center - Credibility: High - Factual Reporting: High - United States of America
    Wikipedia about this source

    Search topics on Ground.News

    https://www.nbcnews.com/health/health-news/sweden-confirms-first-case-mpox-strain-congo-rcna166763
    https://www.nbcnews.com/health/health-news/who-declares-mpox-global-public-health-emergency-second-time-rcna166601

    Media Bias Fact Check | bot support

  • Treczoks@lemmy.world
    link
    fedilink
    English
    arrow-up
    6
    arrow-down
    18
    ·
    3 months ago

    Which means the pharmaceutical companies will actually starting to research on countermeasures. Just like they did with Ebola: While this was raging in Africa and killing PoCs left and right, nobody f-ing cared. As soon as a number of white people got infected, they started hunting for a remedy.

    • TransplantedSconie@lemm.ee
      link
      fedilink
      English
      arrow-up
      17
      arrow-down
      1
      ·
      3 months ago

      They already have a vaccine.

      They already were sending doses to help mitigate the spread. Calm your tits.

      • xor@lemmy.blahaj.zone
        link
        fedilink
        English
        arrow-up
        6
        ·
        3 months ago

        Though it is worth noting that the original commenter very nearly hit on an important point: the vaccines are not accessible enough to communities in Africa, especially in the poorest - often the most impacted - regions.

        Mpox is something we could have stopped long ago with a better system of distributing/purchasing vaccines, like with tuberculosis.

        It is true that when these diseases reach Europe, North America and East Asia, these medicines suddenly start being distributed far more effectively, since that’s where most of the companies that manufacture them are based, and since the countries there are wealthy enough to effectively do so, but only now that it’s an Us Problem™️

    • Mr_Blott@feddit.uk
      link
      fedilink
      English
      arrow-up
      13
      arrow-down
      2
      ·
      3 months ago

      From what I read, the pharmaceutical companies have been on this like a tramp on a sandwich, right from the beginning.

      I think you just haven’t realised that you’re the racist

      • xor@lemmy.blahaj.zone
        link
        fedilink
        English
        arrow-up
        5
        ·
        3 months ago

        They are somewhat right about the fact that the vaccines haven’t been sufficiently accessible in Africa to actually tackle the crisis, though